A Multi-center Retrospective Study of INO Treating B-ALL

NCT07238907 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukaemia
Acute Lymphoblastic Leukaemias (ALL)
Inotuzumab Ozogamicin
Venetoclax

Interventions

DRUG: Inotuzumab Ozogamicin

Sponsor

Ruijin Hospital